Today: 15 May 2026
Browse Category

Earnings Reports 5 February 2026

Coherent stock price whipsaws after earnings: COHR slides as outlook, trade risks come into focus

Coherent stock price whipsaws after earnings: COHR slides as outlook, trade risks come into focus

Coherent shares fell 3.9% to $202.69 in late morning New York trading Thursday after posting fiscal Q2 revenue of $1.69 billion, up 17% from last year. The company expects Q3 revenue between $1.70 billion and $1.84 billion, with non-GAAP EPS forecast at $1.28 to $1.48. Trading volume topped 5.8 million shares after a volatile open. Shares were briefly halted for volatility at 09:38 a.m. ET.
5 February 2026
··
Tapestry stock jumps after Coach Tabby handbag demand drives earnings beat, outlook hike

Tapestry stock jumps after Coach Tabby handbag demand drives earnings beat, outlook hike

Tapestry Inc shares rose 3.8% to $134.87 after reporting a 14% jump in quarterly sales to $2.50 billion and raising its full-year outlook. Coach revenue surged 25% while Kate Spade sales fell 14%. The company now expects fiscal 2026 revenue above $7.75 billion and plans $1.5 billion in shareholder returns. The stock earlier jumped nearly 9% before paring gains.
5 February 2026
··
Palantir stock drops again as AI jitters and valuation doubts bite after earnings whipsaw

Palantir stock drops again as AI jitters and valuation doubts bite after earnings whipsaw

Palantir shares fell 6.8% to $130.11 Thursday morning, extending a two-day slide that erased most of Tuesday’s rally. The drop follows a 12% plunge Wednesday amid concerns over AI-driven valuations and sector volatility. Director Alexander D. Moore disclosed selling 20,000 shares last week. Investors await U.S. economic data next week that could shift rate expectations for growth stocks.
5 February 2026
···
Cardinal Health stock jumps 9% after earnings beat — what CAH investors watch next

Cardinal Health stock jumps 9% after earnings beat — what CAH investors watch next

Cardinal Health shares jumped 9% to $226.05 Thursday after the company raised its fiscal 2026 adjusted earnings forecast to $10.15-$10.35 per share. Quarterly revenue rose 19% and adjusted profit beat estimates, driven by strong specialty drug demand. CEO Jason Hollar cited double-digit profit growth across all segments. Specialty medicines, including GLP-1 drugs, contributed significantly to revenue gains.
5 February 2026
····
Symbotic stock drops in premarket after Q1 outlook — $22.3B backlog and margins in focus

Symbotic stock drops in premarket after Q1 outlook — $22.3B backlog and margins in focus

Symbotic shares fell about 5% to $53.48 in premarket trading after posting $630 million in quarterly revenue and forecasting $650 million to $670 million for the next quarter. The company reported a $13 million profit, up from a $17 million loss a year ago. Needham raised its price target to $75. Investors remain cautious amid project timing swings and concentrated client exposure.
5 February 2026
··
Boston Scientific stock tries to steady after an 18% earnings drop put EP business on edge

Boston Scientific stock tries to steady after an 18% earnings drop put EP business on edge

Boston Scientific shares rose about 1% in Thursday premarket trading after plunging 17.6% Wednesday on weak electrophysiology sales and a softer 2026 outlook. Q4 electrophysiology revenue missed analyst estimates, and U.S. Watchman sales fell short. The stock traded near $76.30 after closing at $75.50. CEO Michael Mahoney said Q4 results beat internal targets but warned of challenges in the first quarter.
5 February 2026
··
Suzlon Energy Q3 results: Profit up 15%, revenue jumps 42% — but shares still slide

Suzlon Energy Q3 results: Profit up 15%, revenue jumps 42% — but shares still slide

Suzlon Energy shares fell nearly 6% to 47.76 rupees on Thursday after Q3 net profit rose 15% year-on-year to 4.45 billion rupees. Revenue from operations jumped 42% to 42.28 billion rupees. The company delivered a record 617 MW in the quarter, with an order book of 6.4 GW as of December 31. Sequential profit dropped 65% from the previous quarter, partly due to a prior deferred tax gain.
5 February 2026
···
AppLovin stock tumbles on CloudX AI threat talk as traders brace for earnings

AppLovin stock tumbles on CloudX AI threat talk as traders brace for earnings

AppLovin shares fell 16.1% Wednesday to $387.34, following a 4.4% drop Tuesday, as trading volume topped 15 million shares. The declines came amid a broader selloff in software stocks and new competition from CloudX, a startup led by a former MoPub co-founder. AppLovin will report fourth-quarter and full-year results on Feb. 11 after the market closes.
5 February 2026
····
Saab stock drops after earnings beat and raised growth target as investors weigh what’s next

Saab stock drops after earnings beat and raised growth target as investors weigh what’s next

Saab shares fell 3.1% Thursday despite reporting record Q4 order bookings of SEK 100.1 billion and raising its 2023–27 sales growth target to 22% annually. Operating profit jumped 67% to SEK 3.26 billion, and the board proposed a higher dividend. Investors focused on execution risks and the lack of detailed 2026 guidance. The stock has tripled over the past year amid rising European defence budgets.
5 February 2026
··
Volvo Car AB stock sinks 22% as Q4 profit slumps and tariffs bite

Volvo Car AB stock sinks 22% as Q4 profit slumps and tariffs bite

Volvo Car AB shares plunged 22% to 23.05 crowns in Stockholm after fourth-quarter adjusted operating profit fell to 1.8 billion crowns, down from 5.6 billion a year earlier. Revenue dropped to 94.4 billion crowns, and gross margin slipped to 15.8%. The company cited tariffs, weak demand, and pricing pressure. Volvo warned of a challenging 2026 and flagged negative cash flow in the first half due to inventory build-up.
5 February 2026
··
Strategy (MSTR) slides premarket as bitcoin nears $70,000 — what to watch before earnings

Strategy (MSTR) slides premarket as bitcoin nears $70,000 — what to watch before earnings

Strategy Inc (MSTR.O) fell 3.2% to $129.09 in premarket trading Thursday after bitcoin dropped over 6% to $71,325. An SEC filing showed Strategy bought 855 bitcoin for $75.3 million last week, funded by share sales and a higher preferred dividend rate. The company reports fourth-quarter results after the close. Coinbase and major bitcoin miners also declined before the open.
5 February 2026
···
IREN stock slides 17% ahead of earnings as bitcoin flirts with $70,000

IREN stock slides 17% ahead of earnings as bitcoin flirts with $70,000

IREN shares fell 17.4% to $44.94 Wednesday amid a sharp selloff in crypto and AI-linked stocks. Bitcoin touched $70,052 in Asian trading, its lowest since November, as investors braced for potential Fed tightening and ETF outflows. IREN will report quarterly results after Thursday’s close, with a conference call at 5 p.m. ET. Other bitcoin miners also posted steep declines premarket.
5 February 2026
········
Qualcomm stock price drops 11% premarket after weak forecast flags memory crunch

Qualcomm stock price drops 11% premarket after weak forecast flags memory crunch

Qualcomm shares fell 11.1% to $132.34 in premarket trading after forecasting weaker March-quarter revenue and earnings due to global memory-chip shortages. CEO Cristiano Amon said supply bottlenecks and rising prices are limiting handset production, especially in China. The company projected fiscal Q2 revenue of $10.2–$11.0 billion and non-GAAP EPS of $2.45–$2.65. Investors await the next update on May 6.
5 February 2026
···
BAE Systems share price slides as buyback update lands and investors eye Feb 18 results

BAE Systems share price slides as buyback update lands and investors eye Feb 18 results

BAE Systems shares fell about 1.5% in early London trading Thursday, extending a two-day slide and closing near 1,847 pence. The company disclosed the purchase of 110,861 shares for cancellation as part of its buyback. Investors are watching a $195 million U.S. Marine Corps vehicle order and ongoing UK strike action ahead of full-year results due February 18.
5 February 2026
···
BP share price slips as oil drops 2% and buyback scrutiny grows before earnings

BP share price slips as oil drops 2% and buyback scrutiny grows before earnings

BP shares fell 0.6% to 474.90 pence in early London trading Thursday, retreating from a one-year high as oil prices dropped and investors awaited earnings. Brent crude slipped 2% to $68.02 a barrel after news of U.S.–Iran talks. BP repurchased 2.7 million shares on Feb. 4 under its ongoing buyback plan. Investors are watching for signals on buybacks and spending when BP reports results Feb. 10.
5 February 2026
···
1 … 51 52 53 54 55 … 247

Stock Market Today

  • ABIVAX Société Anonyme Stock Slides Amid High Valuation and Losses
    May 15, 2026, 12:02 AM EDT. ABIVAX Société Anonyme (ENXTPA:ABVX) saw its stock fall 1.3% over one day, down 3.9% over a week, prompting investor scrutiny. Despite 55.4% revenue growth, the company posted a net loss of €336 million and trades at a price-to-book (P/B) ratio of 18x, compared with the French biotech average of 4.6x. The elevated P/B suggests expectations for future growth rather than current earnings, as ABIVAX remains unprofitable and relies on external borrowing. Analysts note shares trade 86% below fair value estimates based on projected cash flows, but high losses and negative return on equity (73.84%) weigh on sentiment. The stock's premium valuation reflects bullish views on drug pipeline progress, though risks remain amid ongoing clinical trials.

Latest articles

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 15.05.2026

15 May 2026
LIVEMarkets rolling coverageStarted: May 15, 2026, 12:00 AM EDTUpdated: May 15, 2026, 12:11 AM EDT ABIVAX Société Anonyme Stock Slides Amid High Valuation and Losses May 15, 2026, 12:02 AM EDT. ABIVAX Société Anonyme (ENXTPA:ABVX) saw its stock fall 1.3% over one day, down 3.9% over a week, prompting investor scrutiny. Despite 55.4% revenue growth, the company posted a net loss of €336 million and trades at a price-to-book (P/B) ratio of 18x, compared with the French biotech average of 4.6x. The elevated P/B suggests expectations for future growth rather than current earnings, as ABIVAX remains unprofitable and relies on
US Stock Market Today After Hours: Why the Dow Reclaimed 50,000 as AI Stocks Drove Wall Street Higher

US Stock Market Today After Hours: Why the Dow Reclaimed 50,000 as AI Stocks Drove Wall Street Higher

15 May 2026
The Dow closed above 50,000 for the first time Thursday, rising 370 points as AI-driven gains lifted U.S. stocks to record highs. Cisco surged after raising its revenue outlook and announcing $9 billion in AI infrastructure orders, while Nvidia jumped 4.4% on U.S. approval to sell chips to China. Cerebras Systems soared 68% in its market debut. Not all chipmakers advanced, with Qualcomm, Intel, Sandisk, and Micron falling sharply.
Xanadu Quantum Technologies Stock Gets Its First Public Earnings Test—and Losses Still Rule

Xanadu Quantum Technologies Stock Gets Its First Public Earnings Test—and Losses Still Rule

15 May 2026
Xanadu Quantum Technologies reported first-quarter revenue of $2.8 million, up from $0.7 million a year earlier, but net loss widened to $20.6 million. Shares rose 1.9% to $15.13 in late U.S. trading before falling over 3% after hours. The company ended March with $272.5 million in cash and plans a $300 million at-the-market facility. Xanadu began trading on Nasdaq and TSX under XNDU on March 27.
Sidus Space Stock Jumps After Q1 Revenue Rises 51%, But Losses Still Loom

Sidus Space Stock Jumps After Q1 Revenue Rises 51%, But Losses Still Loom

15 May 2026
Sidus Space reported first-quarter revenue of $359,000, up 51% from a year earlier, and a net loss of $5.2 million, narrowing from $6.4 million. Shares rose about 12% after results. Cash stood at $27.3 million at March 31, down from $43.2 million at year-end. The company raised $58.5 million in a direct share offering after the quarter closed.
Go toTop